I Am So Proud!

[Anonymous]

Flebogamma and Grifols are featured prominently in an article in Time about why healthcare costs are out of control in this country. The section on Flebo is on page nine of this article:

http://healthland.time.com/2013/02/20/bitter-pill-why-medical-bills-are-killing-us/8/

 

[Anonymous]

I love this part:


Grifols spokesman Christopher Healey would not discuss what it cost Grifols to produce and ship Alan A.’s dose, but he did say that the company’s average cost to produce its bioscience products, Flebogamma included, was approximately 55% of what it sells them for. However, a doctor familiar with the economics of cancer-care drugs said that plasma products typically have some of the industry’s higher profit margins. He estimated that the Flebogamma dose for Alan A. — which Sloan-Kettering bought from Grifols for $1,400 or $1,500 and sold to Medicare for $2,135 — “can’t cost them more than $200 or $300 to collect, process, test and ship.”

 

[Anonymous]

So much for the lies we have been told about how small the profit margin is in the plasma business. This is one sleazy company.

I love this part:


Grifols spokesman Christopher Healey would not discuss what it cost Grifols to produce and ship Alan A.’s dose, but he did say that the company’s average cost to produce its bioscience products, Flebogamma included, was approximately 55% of what it sells them for. However, a doctor familiar with the economics of cancer-care drugs said that plasma products typically have some of the industry’s higher profit margins. He estimated that the Flebogamma dose for Alan A. — which Sloan-Kettering bought from Grifols for $1,400 or $1,500 and sold to Medicare for $2,135 — “can’t cost them more than $200 or $300 to collect, process, test and ship.”